First-in-Human Study Also Showed the Return of Vasomotion in Patients Treated with the DREAMS 3G Scaffold
September 05, 2023
BIOMAG-I Study OCT Analysis Confirmed That BIOTRONIK’s Newest Resorbable Magnesium Scaffold Resorbed at 12 Months
September 5, 2023 — New data from the BIOMAG-I first-in-human trial shed light on the vascular healing process…
Read More
CASTLE-HTx trial presented in a Hot Line session at ESC Congress 2023
August 31, 2023
Atrial Fibrillation Ablation Improves Outcomes in Patients with End-stage Heart Failure
August 31, 2023 — Atrial fibrillation ablation is associated with lower rates of death, urgent heart transplantation or…
Read More
ECLS-SHOCK trial presented in a Hot Line session at ESC Congress 2023
August 31, 2023
ECLS-SHOCK Trial Reports Mortality Data for Extracorporeal Life Support
August 31, 2023 — Early extracorporeal life support (ECLS) does not improve survival in patients with acute myocardial…
Read More
This is the first international guideline document to include all cardiomyopathy subtypes
August 31, 2023
First International Guidelines on Heart Muscle Diseases Published
August 31, 2023 — The European Society of Cardiology (ESC) Guidelines on cardiomyopathies are published online in …
Read More
Here's a look at what viewers found most interesting during the month of August on dicardiology.com
By Melinda Taschetta-Millane
August 31, 2023
Top 10: A Look at the Hot Topics from August
As we wind down the summer months, DAIC takes a look at the Top 10 most-read pieces of content from www.dicardiology.…
Read More
Non-inferiority and safety of one-month DAPT with BIOTRONIK’s drug-eluting stent presented as late-breaker at ESC 2023
August 30, 2023
12-Month-Data of BIOFLOW-DAPT Study Show Positive Results for Orsiro Mission DES With Short DAPT
August 30, 2023 — BIOFLOW-DAPT one-year-data demonstrated non-inferiority and a good safety profile for the Orsiro …
Read More
MULTISTARS AMI trial presented in a Hot Line session today at ESC Congress 2023
August 30, 2023
Trial Investigates Timing of Complete Revascularization for Myocardial Infarction
August 30, 2023 — Immediate multivessel percutaneous coronary intervention (PCI) is non-inferior to staged multivessel…
Read More
August 30, 2023
Highlights from the ESC Congress 2023
August 30, 2023 — “Joining forces to protect the heart – this was our mission for this year’s ESC Congress,” said…
Read More
Optical coherence tomography (OCT) is non-inferior to intravascular ultrasound (IVUS) for guiding percutaneous coronary intervention (PCI), according to late breaking research presented in a Hot Line session at ESC Congress 2023
August 29, 2023
Optical Coherence Tomography Non-inferior to Intravascular Ultrasound for Stent Guidance
August 29, 2023 — Optical coherence tomography (OCT) is non-inferior to intravascular ultrasound (IVUS) for guiding…
Read More
The European Society of Cardiology (ESC) Guidelines on acute coronary syndromes are published online today in European Heart Journal.
August 29, 2023
First ESC Guidelines Covering All Acute Coronary Syndromes Published
August 29, 2023 — The European Society of Cardiology (ESC) Guidelines on acute coronary syndromes are published online…
Read More
Data from the landmark ILUMIEN IV trial, the first randomized imaging trial with global representation, has the potential to change clinical practice related to stent placement
August 29, 2023
Abbott Unveils Late-breaking Data Showing Intravascular Imaging Via OCT can Improve Stent Procedural Outcomes, Especially in Complex Cases
August 29, 2023 — Abbott announced late-breaking data from the first-of-its-kind ILUMIEN IV OPTIMAL PCI (ILUMIEN IV)…
Read More
The PROFID EHRA trial is set to answer this question in a large, multicentre, EU-funded study set to enrol the first patient this summer.
August 28, 2023
Trial Re-evaluates Routine Defibrillator Implantation After Myocardial Infarction
August 28, 2023 — Is the routine implantation of an implantable cardioverter defibrillator (ICD) in myocardial…
Read More
HEART-FID trial presented in a Hot Line session Saturday at ESC Congress 2023
August 28, 2023
Trial of Ferric Carboxymaltose in Heart Failure Does Not Meet Primary Endpoint
August 28, 2023 — Ferric carboxymaltose(FCM) did not improve a hierarchical outcome of death, heart failure…
Read More
BUDAPEST CRT Upgrade trial presented in a Hot Line Session Saturday at ESC Congress 2023
August 28, 2023
Upgrade to Cardiac Resynchronization Therapy Benefits Heart Failure Patients with Pacing
August 28, 2023 — Upgrade to cardiac resynchronization therapy with a defibrillator (CRT-D) reduces morbidity and…
Read More
STOPDAPT-3 trial presented in a Hot Line Session Saturday at ESC Congress 2023
August 28, 2023
Dual-antiplatelet Therapy Should Remain Standard Strategy After Stent Implantation
August 28, 2023 — Prasugrel monotherapy after percutaneous coronary intervention (PCI) with drug-eluting stents is not…
Read More
Integrating and analyzing data over time and across various data sources, CardioVisio for Atrial Fibrillation helps visualize the history of the patient’s heart and provides guideline-directed insights to healthcare providers
August 24, 2023
GE HealthCare Launches CardioVisio for Atrial Fibrillation, a Digital, Patient-Centric Clinical Decision Support Tool to Enable Precision Care
August 24, 2023 — GE HealthCare announces the launch of CardioVisio for Atrial Fibrillation (AFib), a digital tool…
Read More
Royal Philips, a global leader in health technology, highlighted how it integrates AI in cardiac ultrasound and across cardiac care to help improve clinical confidence and increase efficiency.
August 24, 2023
Philips integrates AI in cardiac ultrasound and across cardiac care at ESC 2023
August 24, 2023 —Royal Philips, a global leader in health technology, highlighted how it integrates AI in cardiac…
Read More
Heart Test Laboratories, Inc. d/b/a HeartSciences, an artificial intelligence (AI)-based medical technology company focused on transforming ECGs/EKGs to save lives through earlier detection of heart disease, announced that its MyoVista wavECG has been selected by PanaceaFlo Ltd to be used in Dublin, Ireland in its heart screening evaluation study
August 24, 2023
HeartSciences’ MyoVista wavECG Selected to be used in Irish Heart Screening Evaluation
August 24, 2023 —Heart Test Laboratories, Inc. d/b/a HeartSciences, an artificial intelligence (AI)-based medical…
Read More
40-site pilot program across US, UK, and Europe aims to introduce cutting edge AI solutions into the clinical environment to improve patient care and efficiency
August 23, 2023
Medtronic Announces First Patient Treated in Global Collaboration with Cydar Medical
August 23, 2023 — Medtronic is announcing the first patient treated in a global pilot program in collaboration with…
Read More
By gently diverting the esophagus, heart ablations will be safer
August 23, 2023
New Device Helps Prevent Complication During Common Heart Procedure
August 23, 2023 — Atrial fibrillation, or AFib , is the most common heart rhythm problem, affecting millions of…
Read More
© Copyright Wainscot Media. All Rights Reserved.
Subscribe Now